Sort
21,281 grants matching “influenza”
Center for Investigating Viral Immunity and Antagonism
$4,042,102Mount Sinai School Of Medicine Of Nyu · U19 · FY2005 · AI
Systems Immunogenetics of Biodefense Pathogens in the Collaborative Cross
$4,030,980Ralph S Baric · Univ Of North Carolina Chapel Hill · U19 · FY2013 · AI
Emerging Infections Program
$4,023,975Dale L Morse · Nysdoh/Health Research, Inc. · U01 · FY2007 · CI
Center for Investigating Viral Immunity and Antagonism
$4,012,038Thomas M Moran · Icahn School Of Medicine At Mount Sinai · U19 · FY2006 · AI
Advanced Development of Universal Vaccines for Influenza
$4,002,853Ly Phan · Versatope Therapeutics, Inc. · N01 · FY2023 · AI
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$4,000,401Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2020 · AI
The Infectious Disease Clinical Research Program (IDCRP)
$4,000,000Timothy Burgess · National Institute Of Allergy And Infectious Diseases · Y01 · FY2020 · AI
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2016 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2017 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2015 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,997Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2014 · HL
The Impact of Tobacco Exposure on the Lungs Innate Defense System
$3,999,996Robert Tarran · Univ Of North Carolina Chapel Hill · P50 · FY2013 · HL
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND RESPONSE
$3,995,257Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2022 · AI
BSL3 Enhancements for RNA Virus Pandemic Preparedness
$3,994,219Hardy Kornfeld · Univ Of Massachusetts Med Sch Worcester · G20 · FY2022 · AI
Small molecule inhibitors of enveloped virus entry
$3,986,024Sean P. J. Whelan · Harvard Medical School · U19 · FY2018 · AI
MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF PANDEMIC FLU
$3,972,316Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · P01 · FY2009 · AI
Center for Investigating Viral Immunity and Antagonism
$3,971,907Mount Sinai School Of Medicine Of Nyu · U19 · FY2004 · AI
Adjuvant development in the context of seasonal and pandemic influenza
$3,971,336Jay Evans · University Of Montana · N01 · FY2020 · AI
Resources, Workforce Development, and Animal Models for the Rutgers RBL
$3,970,689David Alland · Rutgers Biomedical And Health Sciences · UC7 · FY2023 · AI
SUPPORT SURVEILLANCE,RESPONSE TO SEASONAL,PANDEMIC INFLUENZA IN WESTERN PACIFIC
$3,970,538Lee Chin-Kei · World Health Organization-West Pacific · U51 · FY2012 · IP
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$3,966,682John Jay Treanor · University Of Rochester · N01 · FY2015 · AI
MOLECULAR AND BIOLOGICAL CHARACTERIZATION OF PANDEMIC FLU
$3,963,191Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · P01 · FY2010 · AI
Center for Investigating Viral Immunity and Antagonism
$3,960,784Thomas M Moran · Icahn School Of Medicine At Mount Sinai · U19 · FY2007 · AI
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$3,959,354Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Center for Investigating Viral Immunity and Antagonism
$3,959,017Thomas M Moran · Icahn School Of Medicine At Mount Sinai · U19 · FY2008 · AI